Twenty years of epidemiology in fertility regulation

Revue d'Epidemiologie et de Sante Publique

Volumn 44, Issue 6, 1996, Pages 577-587

  Meirik, O ^a   Benagiano, G ^a  

^a WORLD BANK   (United States)

Author keywords

cancer; cardiovascular disease; contraception; ectopic pregnancy; epidemiology; fertility regulation; public health; sexually transmitted diseases

Indexed keywords

CONTRACEPTIVE AGENT; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; SEX HORMONE;

CANCER; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONTRACEPTION; ECTOPIC PREGNANCY; EPIDEMIOLOGY; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; ORAL DRUG ADMINISTRATION; PELVIC INFLAMMATORY DISEASE;

ABORTION, SPONTANEOUS; BEHAVIOR; BIOLOGY; CANCER; CARDIOVASCULAR EFFECTS; CONTRACEPTION; CONTRACEPTIVE METHODS; DISEASES; EPIDEMIOLOGIC METHODS; EPIDEMIOLOGY; EVALUATION; FAMILY PLANNING; FAMILY PLANNING, BEHAVIORAL METHODS; HEALTH; INTELLIGENCE; IUD; LITERATURE REVIEW; MALE STERILIZATION; MENTAL RETARDATION; NEOPLASMS; ORAL CONTRACEPTIVES; ORAL CONTRACEPTIVES, COMBINED; PERSONALITY; PHYSIOLOGY; PREGNANCY COMPLICATIONS; PSYCHOLOGICAL FACTORS; PUBLIC HEALTH; RESEARCH METHODOLOGY; RISK ASSESSMENT; STERILIZATION, SEXUAL; VASECTOMY;

CARDIOVASCULAR DISEASES; CONTRACEPTION; CONTRACEPTIVE AGENTS; EPIDEMIOLOGIC METHODS; FAMILY PLANNING SERVICES; FEMALE; HUMANS; INTRAUTERINE DEVICES; MALE; NATURAL FAMILY PLANNING METHODS; NEOPLASMS; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREGNANCY, ECTOPIC; PROSTATIC NEOPLASMS; PUBLIC POLICY; VASECTOMY;

EID: 0029961812     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (68)

1. Skegg DCG. The epidemiological assessment of hormonal contraceptives : A methodological review. In : Michal F. (Ed) Safety requirements for contraceptive steroids. Cambridge University Press, Cambridge, U.K., 1989, pp. 21-37.
2. Petitti DB, Shapiro S. Strategies for post-registration surveillance of contraceptive steroids. In : Michal F. (Ed) Safety requirements for contraceptive steroids. Cambridge University Press, Cambridge, U.K., 1989, pp. 335-347.
3. Inman HWH. Post-marketing surveillance in the general population ; Editors' introduction and commentary. In : Inman H.W.H. (Ed) Monitoring for drug safety. Second edition. MTP Press, Lancaster, U.K., 1986, pp. 3-11.
4. World Health Organization. Steroid contraception and the risk of neoplasia. WHO Technical Report Series 1978 ; 619.
5. Cancer and Steroid Hormone Study. Combination oral contraceptive use and the risk of endometrial cancer. JAMA 1987 ; 257 : 796-800.
6. WHO Collaborative study of neoplasia and steroid contraception. Invasive cervical cancer and combined oral contraceptives. Br Med J 1985 ; 290 : 961-5.
7. World Health Organization. Oral contraceptives and neoplasia. WHO Technical Report Series 1992 ; 817.
8. Bosch FX et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992 ; 52 : 750-8.
9. Eluf-Neto J et al. Human papilloma-virus and invasive cervical cancer in Brazil. Br J Cancer 1994 ; 69 : 114-9.
10. Rosenfield A et al. The Food and Drug Administration and medroxyprogesterone acetate : What are the issues ? JAMA 1983 ; 249 : 2922-8.
11. Paul C, Skegg DCG, Spears GFS. Depot-medroxy-progesterone (Depot-Provera) and risk of breast cancer. Br Med J 1989 ; 299 : 759-62.
12. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Breast cancer and depot-medroxy-progesterone acetate : a multinational study. Lancet 1991 ; 338 : 833-8.
13. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. Int J Cancer 1991 ; 49 : 186-90.
14. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Depot-medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer. Int J Cancer 1991 ; 49 : 191-5.
15. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. Contraception 1992 ; 45 : 299-312.
16. Vessey MP. Female hormones and vascular disease ; epidemiologic overview. Br J Fam Plann 1980 ; 6 : Suppl. 1-12.
17. Stadel BV. Oral contraceptives and cardiovascular disease. N Engl J Med 1981 ; 305 : 672-7.
18. Bonnar J. Coagulation effects of oral contraception. Am J Obstet Gynaecol 1987 ; 157 : 1042-8.
19. Thorogood M et al. Fatal stroke and use of oral contraceptives : findings from a case-control study. Am J Epidemiol 1992 ; 136 : 35-45.
20. Lidegaard O. Oral contraception and the risk of cerebral thromboembolic attack : results of a case-control study. Br Med J 1993 ; 306 : 956-63.
21. Hannaford PC, Croft PR, Kay CR. Oral contraception and stroke : evidence from the Royal College of General Practitioners' oral contraceptive study. Stroke 1994 ; 25 : 935-42.
22. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. A multinational case-control study of cardiovascular disease and steroid hormone contraceptives : description and validation of methods. J Clin Epidemiol 1995 ; 48 : 1513-47.
23. Spitzer WO, Thorogood M, Heinemann L. Trinational case-control study of OCs and health. Pharmacoepidemiology Drug Safety, 1993 ; 2 : 21-31.
24. Lewis MA et al. Third generation oral contraceptives and risk of myocardial infarction : an international case-control study. Br Med J 1996 ; 312 : 88-90.
25. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives : results of international multicentre case-control study. Lancet 1995 ; 346 : 1575-82.
26. Jick H et al. Risk of idiopathic cardiovascular death and non-fatal thromboembolism in women using oral contraceptives with differing progestogen components. Lancet 1995 ; 346 : 1589-96.
27. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestogens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995 ; 346 : 1582-8.
28. Bloemenkamp KWM et al. Enhancement by Factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestogen. Lancet 199 ; 346 : 1593-6.
29. Spitzer WO et al. Third generation oral contraceptives and risk of venous thromboembolic disorders : an international case-control study. Br Med J 1996 ; 312 : 83-8.
30. Blandau RJ. The female factor in fertility and infertility : I. Effects of delayed fertilization on the development of the pronuclei in rat ova. Fertil Steril, 1952 ; 3 : 349.
31. Blandau RJ, Young WC. Ovum age and pregnancy in the guinea pig : Data from 462 artifically inseminated females. Anat Res 67 ; 1936 : Suppl. 1 : 33.
32. Butcher RL, Fugo NW. Overripeness and the mammalian ova II. Delayed ovulation and chromosome anomalies. Fertil Steril 1967 ; 18 : 297.
33. Chang MC. Effects of delayed fertilization on segmenting ova, blastocysts and fetuses in rabbit. Fed Proc 1952; 11 : 24.
34. Thibault C. Normal and abnormal fertilization in mammals. Adv Biosci 1970 ; 6 : 63.
35. Braden AWH, Austin CR. The fertile life of mouse and rat eggs. Science 1954 ; 120 : 610.
36. Iffy L. The time of conception in pathological gestation. Proc R Soc Med 1963 ; 56 : 1098.
37. Marshall J. Congenital defects and the age of spermatozoa. Int J Fertil 1968 ; 13 : 110.
38. Guerrero R, Lanctôt CA. Aging of fertilizing gametes and spontaneous abortion. Effect of the day of ovulation and the time of insemination. Am J Obstet Gynecol 1970 ; 107 : 263.
39. Gray RH et al. Timing of conception and the risk of spontaneous abortion among pregnancies occurring during the use of natural family planning. Am J Obstet Gynecol 1995 ; 172 : 1567-72.
40. Yongbloet PH. Mental and Physical Handicaps in Connection with Overripeness Ovopathy (thesis, University of Amsterdam). H.E. Stenfert Kroese N.V., Leiden, 1971.
41. Population Reports : Natural Family Planning, Series I, 1974, No. 1, 13.
42. World Health Organization. Mechanism of action, safety and efficacy of intrauterine devices. WHO Technical Report Series 753, Geneva, 1987.
43. Lee NC et al. The intrauterine device and pelvic inflammatory disease revisited : New results from the Women's Health Study. Obstet Gynecol 1988 ; 72 : 1-6.
44. Farley TMM et al. Intrauterine devices and pelvic inflammatory disease : an international perspective. Lancet 1992 ; 339 : 785-8.
45. Beral V. An epidemiological study of recent trends in ectopic pregnancy. Br J Obstet Gynaecol 1975 ; 82 : 775-82.
46. Meirik O. Ectopic pregnancy during 1961-78 in Uppsala County, Sweden. Acta Obstet Gynecol Scand 1981 ; 60 : 545-8.
47. Sivin I. IUD-associated ectopic pregnancies, 1974 to 1984. In : Zatuchni GI et al. (Eds) Intrauterine contraception : advances and future prospects. Philadelphia, Harper & Row, 1985 pp. 340-53.
48. Xu Xiong, Buekens P, Wollest E. IUD use and risk of ectopic pregnancy : a meta-analysis of case-control studies. Contraception 1995 ; 52 : 23-34.
49. Mol BWJ et al. Contraception and the risk of ectopic pregnancy : a meta-analysis. Contraception 1995 ; 52 : 337-41.
50. Bastaman B, Rossing MA, Daling JR. IUD use and risk of tubal pregnancy : an Indonesian case-control study. Int J Epidemiol 1994 ; 23 : 1000-5.
51. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction Task Force on Intrauterine Devices for Fertility Regulation. A multinational case-control study of ectopic pregnancy. Clin Reprod Fertil 1985 ; 3 : 131-43.
52. Rossing MA et al. Past use of an intrauterine device and risk of tubal pregnancy. Epidemiology 1993 ; 4 : 245-51.
53. Alexander NJ, Clarkson TB. Vasectomy increases the severity of diet-induced atherosclerosis in Macaca Fascicularis. Science 1978 ; 201 : 538-41.
54. Massey EJ et al. Vasectomy and health : results from a large cohort study. JAMA 1984 ; 252 : 1023-29.
55. Tang Guang-hua et al. Vasectomy and health : cardio-vascular and other diseases following vasectomy in Sichuan Province, People's Republic of China. Int J Epidemiol 1988 ; 17 : 608-17.
56. Chi IC et al. Vasectomy and cardiovascular deaths in Korean men : a community-based case-control study. Int J Epidemiol 1990 ; 19 : 1113-5.
57. Clarkson TB et al. Atherosclerosis of cynomolgus monkeys hyper- and hypo-responsive to dietary cholesterol : lack of effect of vasectomy. Arteriosclerosis 1988 ; 8 : 488-98.
58. Rosenberg L et al. Vasectomy and the risk of prostate cancer. Am J Epidemiol 1990 ; 132 : 1051-5.
59. Mettlin C et al. Vasectomy and prostate cancer risk. Am J Epidemiol 1990 ; 132 : 1056-61.
60. Sidney S et al. Vasectomy and the risk of prostate cancer in a cohort of multiphasic health-checkup examinees : second report. Cancer Causes Control 1991 ; 2 : 113-6.
61. Giovannucci E et al. A prospective cohort study of vasectomy and prostate cancer in U.S. men. JAMA 1993 ; 269 : 873-7.
62. Giovannucci E et al. A retrospective cohort study of vasectomy and prostate cancer in U.S. men. JAMA 1993 ; 269 : 878-82.
63. Healy B. News from NIH : Does vasectomy cause prostate cancer ? JAMA 1993 ; 269 : 2620.
64. Strader CH et al. Vasectomy and the incidence of testicular cancer. Am J Epidemiol 1988 ; 128 : 56-63.
65. Cale ARJ et al. Does vasectomy accelerate testicular tumour ? Importance of testicular examinations before and after vasectomy. Br Med J 1990 ; 300 : 370.
66. Moller H, Knudson LB, Lynge E. Risk of testicular cancer after vasectomy : cohort study of over 73,000 men. Br Med J 1994 ; 309 : 295-9.
67. Bradford Hill A. The environment and disease : association or causation. Proceed R Soc Med 1965 ; 58 : 295-300.
68. Susser M. Causal thinking in the health sciences. New York University Press, New York, 1973.